Literature DB >> 20576049

Missed congenital heart disease in neonates.

Benton Ng1, John Hokanson.   

Abstract

OBJECTIVES: The purpose of this study was to determine the incidence of missed congenital heart disease in neonates in the state of Wisconsin leading to death or readmission during the first 2 weeks of life.
DESIGN: Wisconsin hospitalization and death records were reviewed from 2002 to 2006. Only those neonates discharged home after birth without a cardiac or major non-cardiac diagnosis were considered. Wisconsin hospital records identified those neonates readmitted during the first 2 weeks of life with a diagnosis of heart disease using International Classification of Diseases, 9th Revision (ICD-9) codes. Wisconsin death records also identified patients who died within the first 14 days of life who had a diagnosis of heart disease using International Classification of Diseases, 10th Revision (ICD-10) codes. Adverse events were attributed to congenital heart disease if the diagnosis was a left-sided obstructive lesion or a cyanotic heart defect. Other adverse events were attributed to heart disease if no other major diagnosis was present and the data suggested an intention to treat. The 114 Wisconsin hospitals, which delivered 340 203 babies during 2002-2006, were stratified into quartiles based on the total number of deliveries to determine if there was a difference in incidence of missed congenital heart disease based on hospital birth size.
RESULTS: Congenital heart disease led to death or rehospitalization during the first 2 weeks of life in 14 out of 345 573 births (1 : 24 684) in Wisconsin between 2002 and 2006. Coarctation of the aorta and hypoplastic left heart syndrome were the most common diagnoses. There did not appear to be a difference in the incidence of missed diagnosis of congenital heart disease based on the number of deliveries performed at the birth hospital.
CONCLUSIONS: Death or readmission events in neonates under 2 weeks of age because of a missed diagnosis of congenital heart disease occurred in 1 : 24 684 neonates in the state of Wisconsin between 2002 and 2006. Critical left sided obstructive lesions were the most common cause of these events.

Entities:  

Mesh:

Year:  2010        PMID: 20576049     DOI: 10.1111/j.1747-0803.2010.00418.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  19 in total

1.  Diagnostic errors in paediatric cardiac intensive care.

Authors:  Priya N Bhat; John M Costello; Ranjit Aiyagari; Paul J Sharek; Claudia A Algaze; Mjaye L Mazwi; Stephen J Roth; Andrew Y Shin
Journal:  Cardiol Young       Date:  2018-02-07       Impact factor: 1.093

2.  Critical Congenital Heart Disease Newborn Screening Implementation: Lessons Learned.

Authors:  Monica R McClain; John S Hokanson; Regina Grazel; Kim Van Naarden Braun; Lorraine F Garg; Michelle R Morris; Kathleen Moline; Keri Urquhart; Amy Nance; Harper Randall; Marci K Sontag
Journal:  Matern Child Health J       Date:  2017-06

3.  Cross-Sectional Survey on Newborn Screening in Wisconsin Amish and Mennonite Communities.

Authors:  Shelby Sieren; Meghan Grow; Matthew GoodSmith; Gretchen Spicer; James Deline; Qianqian Zhao; Mary J Lindstrom; Anne Bradford Harris; Angela M Rohan; Christine M Seroogy
Journal:  J Community Health       Date:  2016-04

4.  Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection?

Authors:  Cora Peterson; April Dawson; Scott D Grosse; Tiffany Riehle-Colarusso; Richard S Olney; Jean Paul Tanner; Russell S Kirby; Jane A Correia; Sharon M Watkins; Cynthia H Cassell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-09-02

5.  Evaluating the diagnostic gap: statewide incidence of undiagnosed critical congenital heart disease before newborn screening with pulse oximetry.

Authors:  Jessica H Mouledoux; William F Walsh
Journal:  Pediatr Cardiol       Date:  2013-04-18       Impact factor: 1.655

Review 6.  Genomics and Epigenomics of Congenital Heart Defects: Expert Review and Lessons Learned in Africa.

Authors:  Nicholas Ekow Thomford; Kevin Dzobo; Nana Akyaa Yao; Emile Chimusa; Jonathan Evans; Emmanuel Okai; Paul Kruszka; Maximilian Muenke; Gordon Awandare; Ambroise Wonkam; Collet Dandara
Journal:  OMICS       Date:  2018-05

7.  Moving towards universal prenatal detection of critical congenital heart disease in southern Nevada: a community-wide program.

Authors:  William Evans; William Castillo; Robert Rollins; Carlos Luna; Katrinka Kip; Joseph Ludwick; Nitin Madan; Michael Ciccolo; Alvaro Galindo; Abraham Rothman; Gary Mayman; Kathleen Cass; Vincent Thomas; Humberto Restrepo; Ruben Acherman
Journal:  Pediatr Cardiol       Date:  2014-08-08       Impact factor: 1.655

8.  Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.

Authors:  Cora Peterson; Scott D Grosse; Matthew E Oster; Richard S Olney; Cynthia H Cassell
Journal:  Pediatrics       Date:  2013-08-05       Impact factor: 7.124

9.  Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry.

Authors:  Cora Peterson; Elizabeth Ailes; Tiffany Riehle-Colarusso; Matthew E Oster; Richard S Olney; Cynthia H Cassell; David E Fixler; Suzan L Carmichael; Gary M Shaw; Suzanne M Gilboa
Journal:  JAMA Pediatr       Date:  2014-04       Impact factor: 16.193

10.  Blood pressure screening for critical congenital heart disease in neonates.

Authors:  Kristi L Boelke; John S Hokanson
Journal:  Pediatr Cardiol       Date:  2014-06-05       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.